← Leaderboards
Howard Li
Va Eastern Colorado Health Care System
$0
Attributed
$0
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2012–16$1$1$1$0$0
'12
'13
'14
'15
'16
Funding mix
By agency
VA$0 · 1
By mechanism
IK2$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Va Eastern Colorado Health Care System
Same institution · by research overlap
- Robert Keith$1,357,712
- Edward N Janoff$11,927,807
Others in their field
Top investigators on “Activating Transcription Factor”
- Angela M. Gronenborn · Diabetes, Digestive, Kidney Diseases$45,640,184
- Eric J Nestler · Icahn School Of Medicine At Mount Sinai$38,773,972
- Richard M Myers · Hudson-Alpha Institute For Biotechnology$36,336,140
- Christophe O Benoist · Harvard Medical School$32,579,283
- Michael G Rosenfeld · University Of California, San Diego$31,114,144
- Prescott G Woodruff · University Of California San Francisco$28,897,138
Research focus
Activating Transcription FactorAdvisory CommitteesAgonistAnimal ModelAnimalsAnticancer ResearchAntidiabetic DrugsAtherosclerosisBlood VesselsBone MarrowBrainCancer CellCancer Cell LineCancer ChemopreventionCancer EtiologyCancer RiskCareerCause Of DeathCellsCell TypeCessation Of LifeCoculture TechniquesColoradoControl Animal
Grant awards (5)
The Role of PPARgamma in Lung Cancer Progression and Metastasis$0
IK2 · FY2016 · VA · contact PI
The Role of PPARgamma in Lung Cancer Progression and Metastasis$0
IK2 · FY2015 · VA · contact PI
The Role of PPARgamma in Lung Cancer Progression and Metastasis$0
IK2 · FY2014 · VA · contact PI
The Role of PPARgamma in Lung Cancer Progression and Metastasis$0
IK2 · FY2013 · VA · contact PI
The Role of PPARgamma in Lung Cancer Progression and Metastasis$0
IK2 · FY2012 · VA · contact PI